Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：11.4 Date：2025-01-21

Journal of Advanced Research

Deficiency of myeloid NPC1 exacerbates liver injury and fibrosis by impairing macrophage efferocytosis

Products：
IF：11.205 Date：2022-11-04

Ebiomedicine

Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosis

Products： ELK5072
IF：11.2 Date：2024-02-28

Cancer Research

β-catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma

Products： EP013
IF：11.2 Date：2024-05-15

CANCER RESEARCH

β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma

Products： ELK1378

< Page of 389 >